Introduction
============

Cardiac remodeling is the response of the heart to various damaging stimuli, such as long standing hypertension or myocardial infarction. This physiological process is characterized by the triggering of "compensatory\" pathways such as, the renin-angiotensin system (RAS) and the sympathetic nervous system (SNS). Initially, this mechanism is beneficial but sustained activation of neurohormonal systems can cause additional damage to the heart, commonly in the form of hypertrophy, apoptosis and fibrosis, contributing to the adverse remodeling process, and accelerating the transition toward heart failure (HF) ([@B16]; [@B15]). Moreover, ventricular remodeling modifies the functioning of ion channels and transporters such as that cardiac rhythm disturbances occur, which is termed "arrhythmogenic remodeling\" ([@B28]). K^+^ currents play key roles in shaping the action potentials (APs), and adverse ventricular remodeling induces down-regulation of several K^+^ currents, which are associated with prolonged QT intervals, increased risk of malignant arrhythmias and sudden cardiac death. It is well known that almost one-half of HF patients die from sudden cardiac death, most probably due to ventricular arrhythmias ([@B27]; [@B19]).

Vitamin D deficiency is highly prevalent worldwide, an in particular among the elderly population ([@B17]). Low levels of vitamin D have been associated with worse outcomes in patients with HF ([@B21]; [@B14]) and vitamin D supplementation has been shown to ameliorate symptoms and decrease mortality ([@B14]; [@B42]). The biologically active form of vitamin D is 1,25-dihydroxycholecalciferol or calcitriol, which translocates the cell membrane and cytoplasm to reached the nucleus of the cell, where it binds to vitamin D receptor (VDR). In turn, VDR can bind to retinoic X receptor to serve as a nuclear transcription factors, regulating the expression of numerous genes. In addition to these genomic responses, calcitriol can mediate rapid responses by binding to cell membrane VDR, interacting with ion channels ([@B24]; [@B44]; [@B37]) and membrane-based signaling pathways ([@B18]).

Previous reports have postulated that activation of the PI3K pathway can modulate cardiac K^+^ channels in cardiomyocytes ([@B43]; [@B13]) and Akt is a well-known target of PI3K, activated by calcitriol in other cellular systems.

Calcitriol has been demonstrated to initiate a VDR-dependent rapid activation of PI3K/Akt signaling in osteoblasts ([@B40]). In addition, the anti-apoptotic properties of calcitriol in osteoblasts are thought to be related to the non-genomic activation of a VDR/PI3K/Akt pathway ([@B46]). Moreover, activation of Akt by calcitriol has also been observed in leukemia, squamous cell carcinoma and skeletal muscle cells ([@B22]; [@B47]; [@B5]).

Vitamin D receptor has been identified in numerous cardiovascular cell types including cardiomyocytes ([@B38]; [@B31]). Whereas experimental studies have demonstrated rapid effects of calcitriol on cardiac calcium channels ([@B44]; [@B37]), its effects on cardiac potassium channels remain elusive. Thus, in the present study we used patch-clamp recordings to examine the rapid responses of calcitriol on the main K^+^ currents responsible for cardiac repolarization in the mouse and the potential mechanism (s) involved. Our results show that calcitriol increases outward K^+^ current densities in ventricular myocytes via Akt signaling, and that this mechanism can contribute to the protective effect of vitamin D on the heart.

Materials and Methods {#s1}
=====================

Animals
-------

Adult (2--3 months old) male C57BL/6J mice and VDR knockout (KO) mice were originally generated by Dr. Marie Demay (Harvard Medical School, Boston, MA, United States) ([@B20]) and kindly donated by Dr Alberto Muñoz (Biomedical Research Institute "Alberto Sols" CSIC-UAM, Madrid, Spain) were used. All experiments on mice were performed after approval by the Bioethical Committee of the *Consejo Superior de Investigaciones Cientificas* following recommendations of the Spanish Animal Care and Use Committee (Proex 035-15) according to the guidelines for ethical care of experimental animals of the European Union (2010/63/EU).

Electrophysiological Procedures and Data Analysis
-------------------------------------------------

Adult mouse ventricular cardiomyocytes were isolated as described ([@B8]). Single rod-shaped, Ca^2+^-tolerant myocytes were treated with calcitriol or vehicle for 15--30 min and used for electrophysiological recordings within 4 h of isolation.

The electrophysiological protocols used to record APs and K^+^ currents in this study were the same as those previously described ([@B39]; [@B4]; [@B12]). Briefly, ventricular myocytes were placed in a chamber mounted on the stage of an inverted microscope and allowed to adhere for 5 min before being superfused with Tyrode's solution. Whole-cell voltage-clamp and current clamp recordings were obtained in the ruptured patch configuration using an Axopatch 200B patch clamp amplifier (Molecular Devices, Sunnyvale, CA, United States). The patch pipette resistance was 1.0--2 MΩ and the pipette was filled with a solution containing (in mM): 135 KCl, 4 MgCl~2~, 5 EGTA, 10 HEPES, 10 glucose, 5 Na~2~ATP, and 5 disodium creatine phosphate; the pH was adjusted to 7.2 with KOH. Whole-cell voltage clamp experiments were performed at room temperature (24--26°C), whereas whole-cell current clamp experiments (AP recordings) were carried out at 36--37°C.

The external solution for K^+^ current recordings contained (in mM): 135 NaCl, 10 glucose, 10 HEPES, 1 MgCl~2~, 1 CaCl~2~, 5.4 KCl, and 2 CoCl~2~; the pH was adjusted to 7.4 with NaOH. The external solution for AP recordings contained (in mM): 140 NaCl, 10 glucose, 10 HEPES, 1.1 MgCl~2~, 1.8 CaCl~2~, and 4 KCl; the pH was adjusted to 7.2 with NaOH.

Current density was calculated from the current amplitude normalized to the membrane capacitance. Membrane capacitance (C~m~) was elicited by applying ±10 mV voltage steps from −60 mV and C~m~ was calculated according to the following equation:
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where τ~c~ is the time constant of the membrane capacitance, I~0~ the maximum capacitance current value, ΔV~m~ the amplitude of the voltage step, and I∞ the amplitude of the steady-state current.

In some experiments the perforated patch-clamp technique was used to record the time course of the effects of calcitriol on total K^+^ currents. Perforated-patch recordings were started 5--25 min after a giga-seal was obtained. Just before use, the tip of the pipette was filled with antibiotic-free intracellular solution and the remainder of the pipette was backfilled with pipette solution containing 250 μg/mL amphotericin B. Depolarizing pulses from a holding potential of −60 to −40 mV were used to monitor the access resistance. Recordings of I~total~ were initiated when the access resistance was stabilized at 6--13 MΩ. I~total~ was elicited by depolarizing pulses to +50 mV from a holding potential of −80 mV every 10 s. The extracellular solution for I~total~ recordings for perforated-patch experiments was the same that we used for the whole-cell experiments. The intracellular solution used to elicit recordings in the perforated-patch configuration contained (in mM): 110 potassium aspartate, 20 KCl, 1 EGTA, 1 CaCl~2~, 5 HEPES, 1 MgCl~2~, 250 μg/mL amphotericin B; pH adjusted to 7.2 with KOH.

Western Blotting
----------------

Cardiomyocytes were homogenized in a buffer containing 320 mM sucrose, 50 mM Tris and 0.2% nonidet P-40, supplemented with a phosphatase, trypsin and protease inhibitor cocktail (Sigma-Aldrich, Madrid, Spain). Lysed cells were centrifuged at 13,000 rpm for 10 min at 4°C and the supernatants were used for immunoblotting. Equal amounts of protein were separated on 10% SDS--PAGE gels and transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% non-fat milk and incubated overnight with the following primary antibodies: phospho-Akt (Thr308) and Akt (Cell Signaling Technology, Danvers, MA, United States)., blots were incubated with peroxidase-conjugated secondary antibodies and immunoreactive bands were detected using the Amersham ECL^TM^ protein detection system (GE Healthcare, Piscataway, NJ, United States) and medical x-ray film blue (Agfa HealthCare, Morstel, Belgium). Films were scanned with a NIKON camera and quantified by ImageJ software (NIH, Bethesda, MD, United States).

Reagents
--------

The Akt inhibitor triciribine, calcitriol and amphotericin B were purchased from Sigma-Aldrich Co. (St. Louis, MO, United States). A stock solution of calcitriol was prepared using DMSO as vehicle (\<0.01% DMSO).

Statistical Analysis
--------------------

Data are presented as means ± SEM. Statistical analysis was performed with GraphPad Prism 5.0 (GraphPad Software Inc., La Jolla, CA, United States). Statistical significance was evaluated using unpaired or paired Student's *t-*test when appropriate. A value of *P* \< 0.05 was considered statistically significant.

Results
=======

Calcitriol Increases Outward K^+^ Currents
------------------------------------------

For the experimental setup, the main K^+^ currents responsible for the AP repolarization phase in the mouse were recorded in ventricular myocytes treated either with vehicle or 10 nM calcitriol for 15--30 min. In the adult mouse ventricle, outward K^+^ currents involved in cardiac repolarization comprise three components that can be distinguished by their specific time and voltage dependency and also their sensitivity to pharmacological agents. **Figure [1](#F1){ref-type="fig"}** illustrates the protocol used to identify the three components: the fast transient outward current (I~tof~), the ultrarapid delayed rectifier K^+^ current (I~kur~) and the non-inactivating steady-state outward current (I~ss~). As a first step the total K^+^ currents were recorded by applying 300 ms depolarizing steps from −50 to +50 mV from a holding potential of −80 mV (**Figure [1A](#F1){ref-type="fig"}**). Then, I~tof~ was inactivated by applying a short prepulse (100 ms step at −30 mV) from a holding potential of −80 mV, followed by depolarizing steps from −50 to +50 mV. I~tof~ was then calculated by substracting the current recording with (**Figure [1A](#F1){ref-type="fig"}**) and without (**Figure [1B](#F1){ref-type="fig"}**) the inactivating prepulse. The current that remains after I~tof~ was inactivated, is composed of I~ss~ and I~Kur~. To separate both currents, a low concentration of 4-aminopyridine (4-AP, 250 μM), which selectively blocks I~kur~, was applied to cells that were prepulsed to inactivate I~tof~. The current remaining after this protocol is I~ss~ (**Figure [1C](#F1){ref-type="fig"}**), and I~kur~ can then be obtained by subtracting the current in the absence (**Figure [1B](#F1){ref-type="fig"}**) and in the presence (**Figure [1C](#F1){ref-type="fig"}**) of 4-AP. **Figure [2A](#F2){ref-type="fig"}** shows representatives recordings of total K^+^ currents obtained in 1 myocyte treated with vehicle and in 1 myocyte treated with 10 nM calcitriol. **Figure [2B](#F2){ref-type="fig"}** shows mean current-voltage (IV) curves for I~total~ density. Myocytes treated with calcitriol showed higher values of I~total~ density than those treated with vehicle (at +50 mV, vehicle 38.2 ± 2.2 pA/pF, *n* = 27; calcitriol 50.5 ± 3.1 pA/pF, *n* = 30; *P* \< 0.01). In another group of experiments we tested the effect of calcitriol on total K^+^ currents by analyzing the time dependence of the effect in continuous recordings. For that, we used the perforated patch-clamp technique which preserves the cell from loss of some cytosolic second messengers due to intracellular dialysis that occurs during prolonged whole-cell recordings. **Figure [2C](#F2){ref-type="fig"}** (upper panel) shows representative traces of I~total~ corresponding to points a, b, and c on the graph below (lower panel). Peak I~total~ was elicited by depolarizing pulses from a holding potential of −80 to +50 mV every 10 s over 19 min. Application of calcitriol induced a rapid increase in I~total~, which reached a maximum effect at 9--10 min; then, the cardiomyocyte was perfused with calcitriol-free solution, which led to a progressive decrease in I~total~ toward control values after ∼10 min of washout. Similar results were obtained in three other cardiomyocytes.

![Protocol used to isolate the fast transient outward K^+^ current (I~tof~), the ultrarapid delayed rectifier K^+^ current (I~kur~) and the non-inactivating steady-state outward current (I~ss~) in mouse ventricular cardiomyocytes. **(A)** Superimposed current records of total K^+^ currents activated by voltage protocol shown on the left. **(B)** Family of K^+^ currents obtained from the same cell as in **(A)** (C~m~ = 212 pF), but voltage-clamp steps were each preceded by an inactivating pulse at −30 mV, shown in the left panel. I~tof~ was then calculated by substracting the current recording with **(A)** and without **(B)** the inactivating prepulse. **(C)** Superimposed current records of K^+^ currents obtained after the same cell as those in **(B)** (C~m~ = 212 pF) was perfused with 4-AP, which selectively blocks I~Kur~. The current remaining after this protocol is I~ss~, and I~kur~ was then obtained by subtracting the current in the absence and in the presence of 4-AP.](fphys-09-01186-g001){#F1}

![Calcitriol increases total K^+^ currents in ventricular myocytes. **(A)** Superimposed current records of total K^+^ current (I~total~) for 1 myocyte treated with vehicle and 1 myocyte treated with 10 nM calcitriol. **(B)** Current-voltage curves for I~total~ density obtained in myocytes treated with vehicle or calcitriol. **(C)** Time course of the effect of calcitriol on I~total~ by perforated patch-clamp recordings. The black points in the figure are peak outward currents recorded at +50 mV every 10 s. Horizontal line indicates exposure to calcitriol 10 nM and washout. Upper panel shows I~total~ traces at +50 mV corresponding to time 0 min **(a)**, 9 min after calcitriol perfusion **(b),** and ∼10 min after washout **(c)**. Data are expressed as means ± SEM. C~m~ = membrane capacitance in pF. ^∗∗∗^*P* \< 0.001; ^∗∗^*P* \< 0.01; ^∗^*P* \< 0.05.](fphys-09-01186-g002){#F2}

**Figure [3A](#F3){ref-type="fig"}** (left panel) shows representative recordings of I~tof~ obtained in 1 myocyte treated with vehicle and in 1 myocyte treated with 10 nM calcitriol a, and **Figure [3A](#F3){ref-type="fig"}** (right panel) shows (IV) curves for I~tof~ density. Myocytes treated with calcitriol showed higher values of I~tof~ density than those treated with vehicle (at +50 mV, vehicle: 10.6. ± 0.9 pA/pF, *n* = 23; calcitriol: 15.9 ± 1.4 pA/pF, *n* = 28; *P* \< 0.01). **Figure [3B](#F3){ref-type="fig"}** (left panel) illustrates representative recordings of I~kur~ obtained in 1 myocyte treated with vehicle and in 1 myocyte treated with 10 nM calcitriol l), **Figure [3B](#F3){ref-type="fig"}** (right panel) shows mean IV curves for I~kur~ density). Myocytes treated with calcitriol showed higher values of I~kur~ density than those treated with vehicle (at +50 mV, vehicle: 13.2 ± 1.2 pA/pF, *n* = 25; calcitriol: 19.4 ± 1.8 pA/pF, *n* = 24; *P* \< 0.01). Representative recordings of I~ss~ obtained in 1 myocyte treated with vehicle and in 1 myocyte treated with 10 nM calcitriol are shown in **Figure [3C](#F3){ref-type="fig"}** left panel, and mean IV curves for I~ss~ density are shown in **Figure [3C](#F3){ref-type="fig"}** right panel. I~ss~ values in myocytes treated with vehicle (at +50 mV, 12.4 ± 0.8 pA/pF, *n* = 12) were similar to those of myocytes treated with calcitriol (at +50 mV, 12.8 ± 0.5 pA/pF, *n* = 26).

![The fast transient outward K^+^ current (I~tof~) and the ultrarapid delayed rectifier K^+^ current (I~kur~) are significantly increased in calcitriol-treated myocytes. **(A)** *Left panel*: representative I~tof~ traces for 1 myocyte treated with vehicle and 1 myocyte treated with 10 nM calcitriol. *Right panel*: I/V curves for I~tof~ density obtained in myocytes treated with vehicle or with 10 nM calcitriol. **(B)** *Left panel*: representative I~kur~ traces for 1 myocyte treated with vehicle and 1 myocyte treated with calcitriol. *Right panel*: I/V curves for I~kur~ density obtained in myocytes treated with vehicle or calcitriol. **(C)** *Left panel*: representative I~ss~ traces for 1 myocyte treated with vehicle and 1 myocyte treated with calcitriol. *Right panel*: IV curves for I~ss~x densities obtained in myocytes treated with vehicle or with calcitri. Data are expressed as means ± SEM. C~m~ = membrane capacitance in pF. ^∗∗∗^*P* \< 0.001; ^∗∗^*P* \< 0.01; ^∗^*P* \< 0.05.](fphys-09-01186-g003){#F3}

Calcitriol Treatment Does Not Modify Action Potentials Duration
---------------------------------------------------------------

Since an increase in outward current can modulate repolarization, we carried out current clamp experiments to measure AP duration (APD) in myocytes treated with vehicle or calcitriol. Representative traces of APs recorded in 1 ventricular myocyte treated with vehicle (left) and in 1 myocyte treated with calcitriol (right) are shown in **Figure [4A](#F4){ref-type="fig"}**. Mean values of APD measured at 20, 50, and 90% of repolarization obtained in ventricular myocytes treated with vehicle or calcitriol are illustrated in **Figure [4B](#F4){ref-type="fig"}**. Values of APD were similar in both groups: APD20, vehicle 1.2 ± 0.6 ms vs. calcitriol 1.3 ± 0.1 ms; APD50, vehicle 3.4 ± 0.3 ms vs. calcitriol 2.9 ± 0.2 ms; APD90, vehicle 25.2 ± 3.5 ms vs. calcitriol 23.5 ± 2.5 ms (*n* = 10 cells treated with vehicle or calcitriol). In addition, no differences were observed in resting potential (RP) or AP amplitude in myocytes treated with vehicle or with calcitriol (−78.3 ± 1.9 mV vs. −77.4 ± 1.4 mV for RP and 117.7 ± 3.7 mV vs. 120.7 ± 3.6 mV for AP amplitude, vehicle vs. calcitriol-treated cells, respectively).

![Effects of calcitriol on Action Potentials Duration **(A)** Representative traces of action potentials recorded in 1 myocyte treated with vehicle and in 1 myocyte treated with 10 nM calcitriol. **(B)** Bar graph showing mean action potential duration (APD) values measured at 20, 50, and 90% of repolarization (APD20, APD50, and APD90, respectively). Data are expressed as means ± SEM.](fphys-09-01186-g004){#F4}

Vitamin D Receptor Is Involved in the Effect of Calcitriol on Outward K^+^ Currents
-----------------------------------------------------------------------------------

To examine the participation of VDR in the effect of calcitriol on I~tof~ and I~kur~, ventricular myocytes were isolated from VDR-KO mice and treated with vehicle or 10 nM calcitriol for 15--30 min. Representative recordings of I~tof~, obtained in 1 VDR-KO myocyte treated with vehicle or 10 nM calcitriol are shown in **Figure [5A](#F5){ref-type="fig"}** left panel, and mean IV curves for I~tof~ density are shown in **Figure [5A](#F5){ref-type="fig"}** right panel. In VDR-deficient myocytes, calcitriol was unable to increase I~tof~ density when compared with vehicle (at +50 mV, vehicle: 13.1 ± 1.8 pA/pF, *n* = 10; calcitriol: 12.5 ± 2.2 pA/pF, *n* = 6). Representative recordings of I~kur~, obtained in 1 VDR-KO myocyte treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol are shown in **Figure [5B](#F5){ref-type="fig"}** (left panel), and mean IV curves for I~kur~ density are shown in **Figure [5B](#F5){ref-type="fig"}** right panel. In the absence of VDR, the mean I~kur~ density was similar between myocytes treated with vehicle or calcitriol (at +50 mV, vehicle: 9.9 ± 1.0 pA/pF, *n* = 6; calcitriol: 11.2 ± 1.4 pA/pF, *n* = 9). Representative recordings of I~ss~, obtained in 1 VDR-KO myocyte treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol are shown in **Figure [5C](#F5){ref-type="fig"}** (left panel), and mean IV curves for I~ss~ density in VDR-KO myocytes treated with vehicle or calcitriol are shown in **Figure [5C](#F5){ref-type="fig"}** right panel. Results showed that calcitriol had no effect on I~ss~ density in VDR-KO myocytes (at +50 mV, vehicle: 8.7 ± 0.6 pA/pF, *n* = 13; calcitriol: 8.8 ± 0.6 pA/pF, *n* = 10).

![Effect of calcitriol on I~tof~ and I~kur~ involves binding to the vitamin D receptor. **(A)** *Left panel*: representative traces of I~tof~ obtained in 1 VDR-KO myocyte treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol. *Right panel*: I/V curves for I~tof~ density obtained in VDR-KO myocytes treated with vehicle or calcitriol. **(B)** *Left panel*: representative traces of I~kur~ obtained in 1 VDR-KO myocyte treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol. *Right panel*: I/V curves for I~kur~ density obtained in VDR-KO myocytes treated with vehicle or calcitriol. **(C)** *Left panel*: representative traces of I~ss~ obtained in 1 VDR-KO myocyte treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol. *Right panel*: I/V curves for I~ss~ density obtained in VDR-KO myocytes treated with vehicle or calcitriol. Data are expressed as means ± SEM. C~m~ = membrane capacitance in pF.](fphys-09-01186-g005){#F5}

Akt Mediates the Stimulatory Effect of Calcitriol on I~tof~ and I~kur~
----------------------------------------------------------------------

It has been postulated that the activation of the PI3K pathway can modulate cardiac K^+^ channels ([@B43]; [@B13]). To explore the implication of PI3K signaling in the calcitriol-induced increase of I~tof~ and I~kur~ densities, we questioned whether calcitriol activates Akt, a known target of PI3K, in ventricular myocytes ([@B35]; [@B23]). We observed a significant activation of Akt (measured as phosphorylation) after 15 min of calcitriol treatment (**Figures [6A,B](#F6){ref-type="fig"}**). We therefore measured I~tof~, I~kur~, and I~ss~ in myocytes pretreated with 1 μM of the Akt inhibitor triciribine. Representative traces obtained in myocytes pretreated with triciribine and then treated with vehicle or calcitriol are shown in **Figures [7A--C](#F7){ref-type="fig"}**, respectively (left panels), and mean IV curves for I~tof~, I~kur~ and I~ss~ densities in both situations are shown in the corresponding right panels. The results showed that treatment with triciribine prevented the stimulatory effect of calcitriol on I~tof~ and I~Kur~.

![Calcitriol activates the Akt pathway in ventricular myocytes. Ventricular myocytes were exposed to vehicle or calcitriol 10 nM for 15 min. **(A)** Representative western blot and **(B)** average ratio of protein levels expressed as the percentage of phospho (P)-Akt normalized to total Akt. Data are expressed as mean ± SEM. ^∗^*P* \< 0.05.](fphys-09-01186-g006){#F6}

![Inhibition of Akt signaling prevents the increase in I~tof~ and I~kur~ densities induced by calcitriol. **(A)** *Left panel*: I~tof~ traces obtained in 1 myocyte treated with 1 μM triciribine and in 1 myocyte treated with 1 μM triciribine plus 10 nM calcitriol. *Right panel*: I/V curves for I~tof~ density obtained in myocytes treated with 1 μM triciribine or with triciribine plus 10 nM calcitriol. **(B)** *Left panel*: I~kur~ traces obtained in one myocyte treated with 1 μM triciribine and in 1 myocyte treated with 1 μM triciribine plus 10 nM calcitriol. *Right panel*: I/V curves for I~kur~ density obtained in myocytes treated with 1 μM triciribine or with triciribine plus 10 nM calcitriol. **(C)** *Left panel*: I~ss~ traces obtained in 1 myocyte treated with 1 μM triciribine and in 1 myocyte treated with 1 μM triciribine plus 10 nM calcitriol. *Right panel*: I/V curves for I~ss~ density obtained in myocytes treated with 1 μM triciribine or with triciribine plus 10 nM calcitriol. Data are expressed as means ± SEM. C~m~, membrane capacitance; TCB, triciribine.](fphys-09-01186-g007){#F7}

Discussion
==========

Cardiac APs are the consequence of the coordinated functioning of inward and outward current flowing through specialized proteins (ionic channels) that open and close in a voltage- and time-dependent manner allowing rhythmic and effective cardiac contractions ([@B11]). It is well known that K^+^ current density is reduced during heart remodeling under various pathological conditions including left ventricular hypetrophy and HF. This process is associated with prolonged QT interval, increased risk of malignant arrhythmias and sudden cardiac death ([@B32]). Here, we tested the hypothesis that calcitriol might have a cardioprotective effect by increasing K^+^ currents, thereby circumventing inappropriate prolongation" of the APD during pathology. In mice, the repolarization phase of the AP is determined principally by the outward currents I~tof~ and I~kur~, which account for the remarkably abbreviated APs and the absence of a clear plateau phase in this species. We found that calcitriol significantly increased I~tof~ and I~kur~ densities. In apparent contrast, we found that the APD was similar in myocytes treated or not with calcitriol. The lack of the effect of increased K^+^ currents on the APD in calcitriol-treated myocytes indicates that calcitriol might affect other ionic currents that influence the APD. In this sense, we previously demonstrated that calcitriol can increase L-type calcium current (I~CaL~) density in ventricular myocytes ([@B37]). The increase of I~CaL~ might counterbalance the effect of increased outward K^+^ currents in calcitriol-treated myocytes, preserving the APD. Calcitriol can induce genomic (transcription-dependent) and non-genomic (transcription-independent) actions. Indeed, there is a general agreement in the idea that calcitriol effects observed within minutes (such as those described in the present study) involve only non-genomic effects mediated by extra-nuclear mechanisms ([@B26]). Most calcitriol actions are mediated by VDR. Classic nuclear VDR is required for genomic effects, whereas non-genomic actions are thought to be mediated by a fraction of VDR located in the cytosol or at the plasma membrane ([@B29],[@B30]). In this regards, *in silico* studies have been useful to determine exactly how calcitriol binds to VDR to regulate both genomic and non-genomic responses. An alternative ligand-binding pocket has been identified in VDR that specifically mediates non-genomic actions and that partially overlaps the genomic pocket described in the experimentally determined x-ray structure ([@B25]). In the present study, we used VDR-KO mice to determine whether the effect of calcitriol on K^+^ currents in cardiomyocytes involves VDR. Our results clearly show that the absence of VDR abolished all changes in K^+^ currents induced by the acute administration of calcitriol, demonstrating that these effects are VDR-dependent. Consistent with this, we have previously described that calcitriol exerts VDR-dependent non-genomic effects on Ca^2+^ current and PKA signaling in cardiomyocytes ([@B37]), which is in line with the findings by [@B45] showing that a functional VDR is required for the rapid increase in Cl- current and for the shift in the peak activation of I~CaL~ current induced by calcitriol in osteoblasts. As VDR-KO mice do not express VDR, this model does not allow us to discriminate precisely which VDR location mediates these observed effects. We are, however, inclined to favor a non-genomic action mediated by membrane VDR due to the short time required (15--30 min) and the fact that VDR has been reported to be expressed in the tubular system of ventricular myocytes ([@B38]), a region where voltage-gated calcium and potassium channels are predominantly localized ([@B36]; [@B3]). On the other hand, protein disulfide isomerase family A member 3 (PDIA3) has been proposed as a membrane receptor for calcitriol that mediates some of its non-genomic effects in chondrocytes, osteoblasts and other cell types ([@B2]; [@B9],[@B10]). Intriguingly, both PDIA3 and VDR are located in caveolae in many tissues and cell types, and an interaction between them has been observed, suggesting that VDR and PDIA3 might both be required for some non-genomic actions of calcitriol ([@B34]; [@B7]). As the effects of calcitriol on K^+^ current in cardiomyocytes are completely abolished in VDR-KO cells we would argue that PDIA3 is not implicated in the described effect, although clearly experiments with PDIA3-KO cells would be necessary to completely discard the possibility that both VDR and PDIA3 are involved.

Several reports have shown that calcitriol binding to plasma membrane VDR induces rapid non-transcriptional responses through the activation of different signaling pathways including PI3K/Akt ([@B5]; [@B33]). This pathway is widely expressed in eukaryotes and is known to play key roles in growth, differentiation, proliferation, and survival ([@B6]). In the heart, PI3K/Akt activation has been related to both physiological cardiac enlargement and protection ([@B23]; [@B41]). Moreover, it is believed that the PI3K/Akt pathway might regulate cardiac ion channels and arrhythmogenesis ([@B1]). Our results show that calcitriol activates Akt in adult ventricular myocytes, and its pharmacological inhibition prevents the calcitriol-induced increase of I~tof~ and I~kur~ densities.

In sum, we demonstrate that calcitriol binding to VDR increases the density of the two main K^+^ currents responsible for the rapid repolarization of the AP in the mouse, I~tof~ and I~Kur~. Our study also supports a role of Akt signaling in this stimulatory effect.
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